← Open Payments lookup

MOLLY PAK: Open Payments

NPI 1588027304 · MOUNT LAUREL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,522 in 42 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,522

Food & beverage: $1,522
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$258
ABBVIE INC.3$250
Ardelyx, Inc.11$218
Takeda Pharmaceuticals U.S.A., Inc.6$184
GENZYME CORPORATION6$178
Janssen Biotech, Inc.1$142
Celltrion USA Inc.1$123
Lilly USA, LLC1$107
Regeneron Healthcare Solutions, Inc.2$33
Phathom Pharmaceuticals, Inc.2$28

Products named: XIFAXAN, IBSRELA, DUPIXENT, TREMFYA, ENTYVIO, ZYMFENTRA, ZEPBOUND, GATTEX.

Industry payments across NJ — which companies pay providers there.